Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03670966
Title 211At-BC8-B10 and Donor Stem Cell Transplant in Treating Relapsed or Refractory AML, ALL, or Myelodysplastic Syndrome
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Fred Hutchinson Cancer Research Center

acute myeloid leukemia

acute lymphoblastic leukemia

myelodysplastic syndrome

chronic myelomonocytic leukemia


BC8-B10 + Cyclophosphamide + Fludarabine

Cyclophosphamide + Filgrastim + Mycophenolate mofetil + Sirolimus + Tacrolimus

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.